NYSEAMERICAN:CTEK - CynergisTek Stock Price, Forecast & News

CynergisTek trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CTEK."

CynergisTek Inc (NYSEAMERICAN:CTEK) issued its earnings results on Monday, November, 11th. The company reported ($0.07) EPS for the quarter. The business had revenue of $4.77 million for the quarter, compared to the consensus estimate of $5.14 million. View CynergisTek's Earnings History.

CynergisTek is scheduled to release their next quarterly earnings announcement on Wednesday, March 25th 2020. View Earnings Estimates for CynergisTek.

1 brokerages have issued twelve-month price objectives for CynergisTek's shares. Their forecasts range from $7.00 to $7.00. On average, they expect CynergisTek's share price to reach $7.00 in the next year. This suggests a possible upside of 112.1% from the stock's current price. View Analyst Price Targets for CynergisTek.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CynergisTek in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CynergisTek.

News articles about CTEK stock have been trending somewhat positive this week, according to InfoTrie. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. CynergisTek earned a daily sentiment score of 1.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for CynergisTek.

CynergisTek saw a increase in short interest in December. As of December 31st, there was short interest totalling 18,800 shares, an increase of 394.7% from the December 15th total of 3,800 shares. Based on an average trading volume of 26,100 shares, the days-to-cover ratio is presently 0.7 days. Approximately 0.2% of the company's shares are short sold. View CynergisTek's Current Options Chain.

Some companies that are related to CynergisTek include Northbridge Industrial Services (NBI), Energy Technologies (EGY), Continental Materials (CUO), Xeros Technology Group (XSG), Tricorn Group (TCN), International Corona Capital (IC), Chamberlin (CMH), Associated British Engineering (ASBE) and Alstom (ALO).

Based on aggregate information from My MarketBeat watchlists, some companies that other CynergisTek investors own include AcelRx Pharmaceuticals (ACRX), Genocea Biosciences (GNCA), SeaChange International (SEAC), SMTC (SMTX), Allena Pharmaceuticals (ALNA), ArQule (ARQL), Digi International (DGII), Ichor (ICHR), Obalon Therapeutics (OBLN) and Signet Jewelers (SIG).

Shares of CTEK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CTEK stock can currently be purchased for approximately $3.30.

CynergisTek has a market capitalization of $34.12 million. CynergisTek employs 292 workers across the globe.View Additional Information About CynergisTek.

The official website for CynergisTek is http://www.cynergistek.com/.

The company can be reached via phone at 949-614-0700.